182 / 464
182
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
POSTERS
> Benefit of semi-extended field radiotherapy in patients with locally
advanced cervical cancer
J. Lee (Taiwan), Y.J. Chen, M.H. Wu, C.L. Chang, T.C. Chen, J.R. Chen,
Y.C. Yang
PO-0712
> Diffusion-weighted MRI for predicting prognosis after radiotherapy in
stage IIIB cervical cancer
Y. Watanabe (Japan), N. Ii, T. Kawamura, Y. Toyomasu, T. Takada,
H. Tanaka, E. Kondo, T. Tabata, H. Sakuma, Y. Nomoto
PO-0713
> Toxicity and clinical Ooutcome of IMRT versus conventional radiation
therapy for endometrial cancer
L. Vaalavirta (Finland), S. Larjavaara, P. Arponen-Esteves, A. Leminen,
J. Collan, M. Harrela, M. Kouri, M. Tenhunen, H. Joensuu
PO-0714
> A phase II study of chemoradiation with tri-weekly cycles of nedaplatin
for uterine cervical cancer.
K. Okuma (Japan), H. Yamashita, R. Kobayashi, K. Nakagawa
PO-0715
> Pelvic insufficiency fracture after IMRT for gynecologic or anal cancer
L. Bazire, H.P. Xu, M. Amessis, C. Malhaire, K. Cao,
A. De La Rochefordière, Y.M. Kirova (France)
PO-0716
> Role of radiation therapy in vulvar cancer patients with one or more
positive inguinal lymph nodes
M.J. Kanis (USA), N. Rydzewski, E.D. Donnelly, J.R. Lurain, J. Strauss
PO-0717
> 18-FDG PET/CT parameters to predict survival and recurrence in
cervical cancer
N. Scher (Switzerland), F. Herrera, A. Depeursinge, T. Breuneval,
J. Bourhis, J. Prior, M. Ozsahin, J. Castelli
PO-0718
> The use of ultrasound bladder scanning in cervical IMRT to reduce
variability of uterine motion
S. Otter (UK), M. Hussein, S. Why, A. Franklin, A. Stewart
PO-0719
> CTV change during adaptive EBRT for cervix cancer: is mid-treatment
plan adaptation required?
D.D. Vignarajah (UK), M.C. Marbán, K.T. Bath, P.J. Hoskin
PO-0720
> Prediction of local recurrence using pretreatment 18FDG PET/CT
radiomics features in cervical cancer
F. Lucia (France), M. Desseroit, O. Miranda, D. Visvikis, J. Malhaire,
P. Robin, O. Pradier, M. Hatt, U. Schick
PO-0721